451 related articles for article (PubMed ID: 18976288)
1. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas.
Elmslie RE; Glawe P; Dow SW
J Vet Intern Med; 2008; 22(6):1373-9. PubMed ID: 18976288
[TBL] [Abstract][Full Text] [Related]
2. Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma.
Burton JH; Mitchell L; Thamm DH; Dow SW; Biller BJ
J Vet Intern Med; 2011; 25(4):920-6. PubMed ID: 21736624
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
[TBL] [Abstract][Full Text] [Related]
4. Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide.
Polton G; Finotello R; Sabattini S; Rossi F; Laganga P; Vasconi ME; Barbanera A; Stiborova K; Rohrer Bley C; Marconato L
Vet Comp Oncol; 2018 Sep; 16(3):399-408. PubMed ID: 29508493
[TBL] [Abstract][Full Text] [Related]
5. Soft-tissue sarcomas in dogs: a review.
Ehrhart N
J Am Anim Hosp Assoc; 2005; 41(4):241-6. PubMed ID: 15995161
[TBL] [Abstract][Full Text] [Related]
6. Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.
London CA; Gardner HL; Mathie T; Stingle N; Portela R; Pennell ML; Clifford CA; Rosenberg MP; Vail DM; Williams LE; Cronin KL; Wilson-Robles H; Borgatti A; Henry CJ; Bailey DB; Locke J; Northrup NC; Crawford-Jakubiak M; Gill VL; Klein MK; Ruslander DM; Thamm DH; Phillips B; Post G
PLoS One; 2015; 10(4):e0124889. PubMed ID: 25923466
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of dogs undergoing surgical resection of mast cell tumors and soft tissue sarcomas: A prospective 2-year-long study.
Milovancev M; Townsend KL; Tuohy JL; Gorman E; Bracha S; Curran KM; Russell DS
Vet Surg; 2020 Jan; 49(1):96-105. PubMed ID: 31044443
[TBL] [Abstract][Full Text] [Related]
8. Single high-dose radiation therapy and liquid fiducial markers can be used in dogs with incompletely resected soft tissue sarcomas.
Ericksen T; Mauldin N; Dickinson R; Mauldin G
J Am Vet Med Assoc; 2023 Oct; 261(10):1-8. PubMed ID: 37437890
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
Kuntz CA; Dernell WS; Powers BE; Devitt C; Straw RC; Withrow SJ
J Am Vet Med Assoc; 1997 Nov; 211(9):1147-51. PubMed ID: 9364229
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of local toxic effects and outcomes for dogs undergoing marginal tumor excision with intralesional cisplatin-impregnated bead placement for treatment of soft tissue sarcomas: 62 cases (2009-2012).
Bergman NS; Urie BK; Pardo AD; Newman RG
J Am Vet Med Assoc; 2016 May; 248(10):1148-56. PubMed ID: 27135671
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004).
Bacon NJ; Dernell WS; Ehrhart N; Powers BE; Withrow SJ
J Am Vet Med Assoc; 2007 Feb; 230(4):548-54. PubMed ID: 17302554
[TBL] [Abstract][Full Text] [Related]
12. Marginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996-2006).
Stefanello D; Morello E; Roccabianca P; Iussich S; Nassuato C; Martano M; Squassino C; Avallone G; Romussi S; Buracco P
Vet Surg; 2008 Jul; 37(5):461-5. PubMed ID: 18986313
[TBL] [Abstract][Full Text] [Related]
13. Radiation treatment for incompletely resected soft-tissue sarcomas in dogs.
McKnight JA; Mauldin GN; McEntee MC; Meleo KA; Patnaik AK
J Am Vet Med Assoc; 2000 Jul; 217(2):205-10. PubMed ID: 10909459
[TBL] [Abstract][Full Text] [Related]
14. Postoperative radiotherapy for canine soft tissue sarcoma.
Forrest LJ; Chun R; Adams WM; Cooley AJ; Vail DM
J Vet Intern Med; 2000; 14(6):578-82. PubMed ID: 11110377
[TBL] [Abstract][Full Text] [Related]
15. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas.
McSporran KD
Vet Pathol; 2009 Sep; 46(5):928-33. PubMed ID: 19429989
[TBL] [Abstract][Full Text] [Related]
16. Metronomic chemotherapy.
Mutsaers AJ
Top Companion Anim Med; 2009 Aug; 24(3):137-43. PubMed ID: 19732732
[TBL] [Abstract][Full Text] [Related]
17. Tolerability of metronomic administration of lomustine in dogs with cancer.
Tripp CD; Fidel J; Anderson CL; Patrick M; Pratt C; Sellon R; Bryan JN
J Vet Intern Med; 2011; 25(2):278-84. PubMed ID: 21314727
[TBL] [Abstract][Full Text] [Related]
18. Orthovoltage radiation and weekly low dose of doxorubicin for the treatment of incompletely excised soft-tissue sarcomas in 39 dogs.
Simon D; Ruslander DM; Rassnick KM; Wood CA; Frimberger AE; Cotter SM; King NW; Moore AS
Vet Rec; 2007 Mar; 160(10):321-6. PubMed ID: 17351172
[TBL] [Abstract][Full Text] [Related]
19. Intentional marginal excision of canine limb soft tissue sarcomas followed by radiotherapy.
Demetriou JL; Brearley MJ; Constantino-Casas F; Addington C; Dobson J
J Small Anim Pract; 2012 Mar; 53(3):174-81. PubMed ID: 22931399
[TBL] [Abstract][Full Text] [Related]
20. High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors.
Spugnini EP; Buglioni S; Carocci F; Francesco M; Vincenzi B; Fanciulli M; Fais S
J Transl Med; 2014 Aug; 12():225. PubMed ID: 25143012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]